1[1]KINLAY S,GANZ P.Endothelial dysfunction in coronary artery disease and implications for therapy[J].Am J Cardiol,1997,80(9A):11-16.
2[2]INOKUCHI K,HIROOKA Y,SHIMOKAWA H,et al.Role of endothelium-derived hyperpolarizing factor in human forearm circulation[J].Hypertension,2003,42(5):919-924.
3[3]ANDERSON T J,GERHARD M D,MEREDITH I T,et al.Systemic nature of endothelial dysfunction in atherosclerosis[J].Am J Cardiol,1995,75(6):71B-74B.
4[4]SUWAIDI J A,HAMASAKI S,HIGANO S T,et al.Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction[J].Circulation,2000,101(9):948-954.
5[5]JADHAV U M,SIVAARAMAKRISHAN A,KADAM N N.Noinvasive assessment of endothelial dysfunction by brachial artery flow-mediatation in prediction of coronary artery disease in Indian subjects[J].Indian Heart J,2003,55(1):44-48.
6[6]MONROE V S,KERENSKY R A,RIVERA E,et al.Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes[J].J Am Coll Cardiol,2003,41(4 suppl s):23s-30s.
7[7]KINLAY S,SELWYN A P.Effects of statines on inflammation in patients with acute and chronic coronary syndromes[J].Am J Cardiol,2003,91(4A):9B-13B.
8[8]FEELISCH M,BRANDS F,KELM M.Human endothelial cells bioactivate organic nitrates to nitric oxide: implications for the reinforcement of endothelial defense mechanisms[J].Eur J Clin Invest,1995,25(10):737-745.
9[9]MANCINI G B,HENRY G C,MACAYA C,et al.Angiotensin-converting enzymeinhibiti on with quinapril improve sendot helial vasomotor dys functionin patient s with coronaryartery disease.The TREND(Trialon Reversing Endothelial Dysfunction) Study[J].Circulation,1996,94(3):258-265.
10[10]KOGA N.Meaning of low-density lipoprotein-apheresis for hypercholesterolemic patients at high risk for recurrence of coronary heart disease[J].Ther Apher,2002,6(5):372-380.
